BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31075428)

  • 1. Conserved B and T cell epitopes prediction of ebola virus glycoprotein for vaccine development: An immuno-informatics approach.
    Ahmad B; Ashfaq UA; Rahman MU; Masoud MS; Yousaf MZ
    Microb Pathog; 2019 Jul; 132():243-253. PubMed ID: 31075428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules.
    Jain S; Baranwal M
    J Theor Biol; 2019 Mar; 465():34-44. PubMed ID: 30639295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
    Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 5. Conserved peptide vaccine candidates containing multiple Ebola nucleoprotein epitopes display interactions with diverse HLA molecules.
    Jain S; Baranwal M
    Med Microbiol Immunol; 2019 Apr; 208(2):227-238. PubMed ID: 30790057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced
    Chabot S; Gimie Y; Obeid K; Kim J; Meseda CA; Konduru K; Kaplan G; Sheng Fowler L; Weir JP; Peden K; Major ME
    J Virol; 2022 Sep; 96(18):e0116621. PubMed ID: 36069549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins.
    Wu S; Yu T; Song X; Yi S; Hou L; Chen W
    Virol J; 2012 Jun; 9():111. PubMed ID: 22695180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B and T Cell Epitope-Based Peptides Predicted from Evolutionarily Conserved and Whole Protein Sequences of Ebola Virus as Vaccine Targets.
    Yasmin T; Nabi AH
    Scand J Immunol; 2016 May; 83(5):321-37. PubMed ID: 26939891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
    Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational design of a potential multi-epitope subunit vaccine using immunoinformatics to fight Ebola virus.
    Kadam A; Sasidharan S; Saudagar P
    Infect Genet Evol; 2020 Nov; 85():104464. PubMed ID: 32681997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and evaluation of DNA vaccine encoding Ebola virus glycoprotein fused with lysosome-associated membrane protein.
    Liu Y; Sun B; Pan J; Feng Y; Ye W; Xu J; Lan M; Sun H; Zhang X; Sun Y; Yang S; Shi J; Zhang F; Cheng L; Jiang D; Yang K
    Antiviral Res; 2021 Sep; 193():105141. PubMed ID: 34274417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus.
    Tsuda Y; Caposio P; Parkins CJ; Botto S; Messaoudi I; Cicin-Sain L; Feldmann H; Jarvis MA
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1275. PubMed ID: 21858240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes.
    Sundar K; Boesen A; Coico R
    Virology; 2007 Apr; 360(2):257-63. PubMed ID: 17123567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
    Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
    BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species.
    Hensley LE; Mulangu S; Asiedu C; Johnson J; Honko AN; Stanley D; Fabozzi G; Nichol ST; Ksiazek TG; Rollin PE; Wahl-Jensen V; Bailey M; Jahrling PB; Roederer M; Koup RA; Sullivan NJ
    PLoS Pathog; 2010 May; 6(5):e1000904. PubMed ID: 20502688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome.
    Lim WC; Khan AM
    BMC Genomics; 2018 Jan; 19(Suppl 1):42. PubMed ID: 29363421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.
    Brannan JM; Froude JW; Prugar LI; Bakken RR; Zak SE; Daye SP; Wilhelmsen CE; Dye JM
    J Infect Dis; 2015 Oct; 212 Suppl 2():S282-94. PubMed ID: 25943199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of Ebola virus dominant and subdominant glycoprotein epitopes facilitates construction of an epitope-based DNA vaccine able to focus the antibody response in mice.
    Mitchell DAJ; Dupuy LC; Sanchez-Lockhart M; Palacios G; Back JW; Shimanovskaya K; Chaudhury S; Ripoll DR; Wallqvist A; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2883-2893. PubMed ID: 28699812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approach.
    Tahir Ul Qamar M; Bari A; Adeel MM; Maryam A; Ashfaq UA; Du X; Muneer I; Ahmad HI; Wang J
    J Transl Med; 2018 Oct; 16(1):298. PubMed ID: 30368237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.